Memic has set out to transform robot-assisted surgery, with proprietary technology that has the potential to far surpasses today’s best solutions. Providing unprecedented access and maneuverability, our Memic’s Hominis™ surgical platform features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation for various access configurations. Dramatically smaller, more versatile, and less costly than current robotic platforms, our technology opens up a host of minimally -invasive procedures that until now have been off-limits to robot-assisted surgery. Some pipeline indications include abdominal single and multi-port surgery, as well as procedures performed in a trans-oral approach. We envision a near future where numerous indications – and millions of patients – will benefit from these disruptive capabilities.

our people
  • Dvir Cohen CEO

    Dvir brings extensive experience in robotic, innovative, and challenging systems. Having led Memic from the inception of the idea, he brought the technology from academia to the tech incubator, performed comprehensive market research to identify an unmet clinical need for trans-vaginal approach to gynecology, and developed the early prototypes. Proving the feasibility of this unique approach, he then built a strong scientific team, moving from prototype to a product that was tested in animal models and cadaveric studies, and performing several multi-center clinical studies in gynecology.

    Previously, Dvir served in an elite group of the Ministry of Defense, leading R&D teams for precise motion systems and sub-micron accuracy robotic systems. In this capacity, he shepherded unique products from concept to prototyping and V&V, developing and implementing production lines for manufacturing and calibration.

    Dvir holds a B.Sc and M.Sc in mechanical engineering from the Technion’s Brakim excellence program, and an MBA in technology, innovation, and entrepreneurship from Recanati Business School. For his contribution to a high-end robotic device, he was recognized as an outstanding officer by the IDF’s Chief of General Staff.

    Yaron Levinson VP R&D

    Yaron has led the development of the Hominis System from the tech incubator to a fully-operational surgical system.
    He previously served as system and control manager at Medical Surgery Technologies (MST) and as founder and CEO of Paragon Measure, Inc.
    He holds a B.Sc and M.Sc in mechanical engineering from Ben Gurion University and a Ph.D in control, signal processing, and optimization from the Technion, and completed a Runway start-up postdoc in mobile health and machine learning at Cornell Tech.

    Einav Yemini VP RA

    Einav leads Memic’s regulatory department, and has established a robust regulatory process with the FDA for a de novo pathway.
    Previously, she was the regulatory associate at Intuitive Surgical. She has broad experience with single-port robotic instruments, multiple submissions of 510(k) files to the FDA, and as an RA, design, and specification engineer at IVT Medical.
    Einav holds a B.Sc in biomedical engineering from Tel Aviv University, and has served as research assistant at the neurogenomics lab at Sheba Medical Center.

    Hagai BerkovichCOO

    As Memic’s COO, Hagai has led the company’s production line analysis and scale-up.
    He previously served as COO at Motorika; as CEO at Tamuz F.T.K Solutions; as operation airborne structure director at Elbit Systems – Cyclone; and as business unit VP at Sanmina SCI Israel Medical Systems.
    He holds MBA from Tel Aviv University, and a B.Sc in aeronautical engineering from the Technion.

    Michal VasiliverVP QA & CA

    Michal leads Memic’s quality and clinical department, and has managed several multi-center studies in Europe and Israel.
    She previously served as VP of QA at BioControl Medical; and as director of QA and RA at CoreAssist Cardiovascular, IBI, and Allium Medical.
    She holds a BA in biology and a B.Sc in food engineering and biotechnology from the Technion, and an MBA from the Interdisciplinary Center in Herzlyia.

  • Maurice Ferre Chairman of the Board

    Maurice R. Ferré MD is INSIGHTEC’S CEO and chairman of the board of directors. He brings over 20 years of experience in the medical device industry. Before INSIGHTEC, Dr. Ferré served as chairman of the board and CEO of MAKO Surgical Corp., a transformational robotic surgical company that he co-founded in 2004. The company was IPO’d in 2008 and sold to Stryker Corp. for $1.65 billion in 2013. Prior to MAKO, Dr. Ferré was founder, CEO, and president of Visualization Technology, Inc., which became the world leader in image-guided surgery for ENT, cranial, and orthopedic procedures. The company was acquired by GE Healthcare in 2002.
    Dr. Ferré earned his Doctor of Medicine and Master of Public Health degress from Boston University. He received the prestigious Ernest & Young 2007 Entrepreneur of the Year Award. He is currently active on the boards of Advamed, the Everglades Foundation, and Boston University.

    About INSIGHTEC: the company’s MR-guided focused ultrasound technology allows to perform procedures with surgical precision but without incisions, thus transforming the standard of care. The company’s non-invasive Exablate and Exablate Neuro platforms are clinically proven for treating essential tremor, painful bone metastases, and uterine fibroids. INSIGHTEC continuously invests in and expanding its current and investigational applications.

    Eyal Lifschitz Chairman of Board's Business Committee

    Eyal Lifschitz is CEO, general partner, and co-founder of Peregrine Ventures.
    Prior to founding Peregrine, Eyal co-founded and led the business development efforts of multiple medical technology companies, including PharmaSys (acquired by Elan Corp. NYSE:ELN), ECR (acquired by AVX Corp. NYSE:AVX), Visioncare Ophthalmic Technologies, and BioControl Ltd. From 2003-2007, Eyal also served as a director of Given Imaging (NASDAQ: GIVN).

    Peregrine is an Israeli venture capital fund, with a focus on medical devices and an impressive record of founding, managing, and promoting Israeli hi-tech companies. Peregrine enjoys a wide network of contacts, and is supported by a investment committee and advisory board consisting of expert teams specializing in all applicable disciplines. The fund has invested in and initiated some of Israel’s leading medical companies, including Neovasc, B-Balloon, Valtech, Eximo, Memic, and Cordio.

    Lior Shahory Board Member

    Lior brings extensive experience in investment due diligence, strategic planning, project management, and business development. He works closely with entrepreneurs to establish successful companies.
    Lior serves as CEO of Incentive, Peregrine’s technology incubator. Under his leadership, Incentive has received seven excellence awards from the State of Israel.
    Prior to Peregrine, Lior served as deputy director of the Israel Chief Scientist’s incubator program.
    Lior holds a BA in economics and business management from the University of Haifa, and an MBA from Tel Aviv University.

    Dr. Irit Yaniv M.D., MBA Board Member

    Dr. Irit Yaniv is a seasoned medtech executive, and has held CEO positions at medical device companies Impulse Dynamics and MetaCure.
    Dr. Yaniv plays a key role in leading Accelmed’s early-stage portfolio companies, serving either as chairperson or as an active board member.
    Dr. Yaniv holds an MD degree from Ben Gurion University, and an MBA from the Recanati Business School at Tel Aviv University.

    Accelmed is an investment firm focused on creating value for medical device companies and technologies. Founded by Mori Arkin and Uri Geiger. It invests in small and mid-cap private and public companies. A successful advocate of the platform model with a proven track record, Accelmed boasts a large team of accomplished investment professionals. Its vision is to create leading med-tech players by merging commercial platforms with small innovative growth companies, predominantly from Israel.

    Yigal Cohen Orgad Board Member

    Mr. Cohen-Orgad has served as Israel’s Minister of Finance, as a director of Bezeq Israel Telecommunication Corp., and as a director of Israel Electric Corporation. He is Chancellor of Ariel University, and sits on the board of Ariel University’s R&D company.

    Ariel Scientific Innovations is a leading technology transfer company committed to transforming Ariel University (AU) technologies into products with a positive impact on society.
    Ariel Scientific Innovations acts as a professional partner to AU researchers, by identifying innovations, patenting inventions, supporting applied research, and commercializing the results to selected commercial partners.

    Dr. Israel Frieder Board Member

    Dr. Israel Frieder serves as independent director at RiT Technologies, Ltd., as chairman at AA Pearl Investments, Ltd., as chairman at ETV Energy, Ltd., and as chairman at IP Light, Ltd. He has served on the board of directors at Cellvine Ltd. and at RR Media Ltd.
    He received his graduate degree from the Technion, an MBA from the Hebrew University of Jerusalem, and a doctorate degree from Bar-Ilan University.

    Dr. Morry Blumenfeld Board Observer

    Dr. Morry Blumenfeld is president and CEO of medical device consulting company Quescon Consultants, Ltd., and a partner at Meditech Advisors, LLC. He was an executive at GE for nearly 35 years, and served GE Medical Systems Business in numerous roles, including initiating both the CT and MRI businesses, and as managing director of GE Medical Systems in Israel.
    Morry holds five patents, and serves or has served on the boards of a number of medical device and technology companies in the USA and Israel – as well as numerous Canadian, international, and Israeli advisory boards in technology and science. He is on the board of the Hebrew University and Yissum (the Hebrew University’s tech transfer company), and on the scientific advisory board of the Momentum Fund of Ramot (Tel Aviv University’s tech transfer company).
    Dr. Blumenfeld received his undergraduate degree and Ph.D from the University of Toronto.

    Guy ShamirBoard Observer

    Mr. Guy Shamir has served as business development manager at Mivtach Shamir Holdings, Ltd. since 2011.
    He previously served as a director at Tefron, Ltd., and as a director at Manif Financial Services, Ltd.
    He holds a degree in business administration from the Interdisciplinary Center in Herzliya.

    Mivtach Shamir Holdings is an investment company based in Israel, led by Israeli investor Meir Shamir. Mivtach Shamir invests in three sectors: technology and communications, industrial investments, and real estate. Shares of Mivtach Shamir are traded on the Tel Aviv Stock Exchange (TASE: MISH).

back to top
think nimble

think nimble

think boundless

think boundless

clinical spectrum
think forward

think forward

news & events
think together

think together

contact us